Avis Budget Group, Inc.

New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis" or the "Company") (NASDAQ: CAR) on behalf of investors that purchased or otherwise acquired Avis securities between February 20, 2025 and April 21, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Avis and have suffered losses, you may CLICK HERE to contact us.

Avis Budget Group, Inc. (NASDAQ: CAR - Get Free Report)'s share price gapped down before the market opened on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $166.32, but opened at $150.07. Avis Budget Group shares last traded at $145.0590, with a volume of 132,324 shares changing hands. The business services provider

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company developing in vivo CAR-T therapies for immune-mediated diseases. Johnson & Johnson will collaborate with Sail to advance its lead immune-mediated disease program and broader platform technology, with incentives to expand the application of Sail's in vivo CAR-T platform across additional therapeutic targets over.

Avis Budget lost money in 2025. 2026 will probably be better than that -- but still not good enough for Wall Street.